Prostate cancer: Bicalutamide dose increase in castration-resistant disease. [electronic resource]
- Nature reviews. Urology Mar 2015
- 132-3 p. digital
Publication Type: Journal Article; Comment
1759-4820
10.1038/nrurol.2014.334 doi
Androgen Antagonists--therapeutic use Anilides--therapeutic use Antineoplastic Agents--therapeutic use Humans Male Orchiectomy Prostatic Neoplasms--drug therapy